| Number(n=) | Percent (%) |
---|---|---|
Gender | ||
 female | 114 | 100 |
Tumor location | ||
 medial/central | 20 | 17.5 |
 lateral | 94 | 82.5 |
Molecular subtype | ` | Â |
 Her2 negative (HR+) | 35 | 30.7 |
 Her2 positive (HR+/−) | 39 | 34.2 |
 TNBC | 40 | 35.1 |
Tumor staging | ||
 I | 16 | 14.0 |
 IIA | 30 | 26.3 |
 IIB | 28 | 24.6 |
 IIIA | 17 | 14.9 |
 IIIB | 8 | 7.0 |
 IIIC | 15 | 13.2 |